Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells
Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune resp...
Gespeichert in:
Veröffentlicht in: | AIDS research and human retroviruses 2004-03, Vol.20 (3), p.315-325 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 325 |
---|---|
container_issue | 3 |
container_start_page | 315 |
container_title | AIDS research and human retroviruses |
container_volume | 20 |
creator | NORRIS, Philip J MOFFETT, Howell F BRANDER, Christian ALLEN, Todd M O'SULLIVAN, Kristin M COSIMI, Lisa A KAUFMANN, Daniel E WALKER, Bruce D ROSENBERG, Eric S |
description | Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development. |
doi_str_mv | 10.1089/088922204322996554 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71879751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71879751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</originalsourceid><addsrcrecordid>eNplkDFPwzAUhC0EoqXwBxiQF1hQwI797HhEhVKkSgwU1sh5saugNClxitR_T0KDQGJ6w_vudHeEnHN2w1liblmSmDiOmRRxbIwCkAdkzI3gUSIZHJJxD0QdYUbkJIR3xljHwzEZceBcS4AxeZkVlaNh47DwBRbtjtoqp9jUIURY2tzRxllsi8_-VXs6f3qj7W7jKKcru4p-hHR6L6_pkqIry3BKjrwtgzsb7oS8zh6W03m0eH58mt4tIhRatJHwEoF1eZnpemAGIECBUY6pPJMxR5lIrgww7VEj9yZTIDQ65R06RCMm5Grvu2nqj60LbbouQp_AVq7ehlTzRBsNvAPjPfjdq3E-3TTF2ja7lLO0nzL9P2Unuhjct9na5b-SYbsOuBwAG9CWvrEVFuEPpzgDZsQX7154zQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71879751</pqid></control><display><type>article</type><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</creator><creatorcontrib>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</creatorcontrib><description>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</description><identifier>ISSN: 0889-2229</identifier><identifier>EISSN: 1931-8405</identifier><identifier>DOI: 10.1089/088922204322996554</identifier><identifier>PMID: 15117455</identifier><identifier>CODEN: ARHRE7</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>AIDS/HIV ; Amino Acid Sequence ; Biological and medical sciences ; CD4-Positive T-Lymphocytes - immunology ; Clone Cells ; Cross Reactions ; Epitope Mapping ; Epitopes, T-Lymphocyte - chemistry ; Epitopes, T-Lymphocyte - immunology ; Fundamental and applied biological sciences. Psychology ; HIV Core Protein p24 - chemistry ; HIV Core Protein p24 - genetics ; HIV Core Protein p24 - immunology ; HIV Infections - immunology ; HIV Infections - virology ; HIV-1 - chemistry ; HIV-1 - genetics ; HIV-1 - immunology ; Human viral diseases ; Humans ; Infectious diseases ; Interferon-gamma - metabolism ; Lymphocyte Activation ; Medical sciences ; Microbiology ; Miscellaneous ; Molecular Sequence Data ; Peptides - chemistry ; Peptides - pharmacology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Virology</subject><ispartof>AIDS research and human retroviruses, 2004-03, Vol.20 (3), p.315-325</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</citedby><cites>FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3029,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15610509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15117455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NORRIS, Philip J</creatorcontrib><creatorcontrib>MOFFETT, Howell F</creatorcontrib><creatorcontrib>BRANDER, Christian</creatorcontrib><creatorcontrib>ALLEN, Todd M</creatorcontrib><creatorcontrib>O'SULLIVAN, Kristin M</creatorcontrib><creatorcontrib>COSIMI, Lisa A</creatorcontrib><creatorcontrib>KAUFMANN, Daniel E</creatorcontrib><creatorcontrib>WALKER, Bruce D</creatorcontrib><creatorcontrib>ROSENBERG, Eric S</creatorcontrib><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><title>AIDS research and human retroviruses</title><addtitle>AIDS Res Hum Retroviruses</addtitle><description>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</description><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Clone Cells</subject><subject>Cross Reactions</subject><subject>Epitope Mapping</subject><subject>Epitopes, T-Lymphocyte - chemistry</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Core Protein p24 - chemistry</subject><subject>HIV Core Protein p24 - genetics</subject><subject>HIV Core Protein p24 - immunology</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - chemistry</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - immunology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Interferon-gamma - metabolism</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Molecular Sequence Data</subject><subject>Peptides - chemistry</subject><subject>Peptides - pharmacology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Virology</subject><issn>0889-2229</issn><issn>1931-8405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkDFPwzAUhC0EoqXwBxiQF1hQwI797HhEhVKkSgwU1sh5saugNClxitR_T0KDQGJ6w_vudHeEnHN2w1liblmSmDiOmRRxbIwCkAdkzI3gUSIZHJJxD0QdYUbkJIR3xljHwzEZceBcS4AxeZkVlaNh47DwBRbtjtoqp9jUIURY2tzRxllsi8_-VXs6f3qj7W7jKKcru4p-hHR6L6_pkqIry3BKjrwtgzsb7oS8zh6W03m0eH58mt4tIhRatJHwEoF1eZnpemAGIECBUY6pPJMxR5lIrgww7VEj9yZTIDQ65R06RCMm5Grvu2nqj60LbbouQp_AVq7ehlTzRBsNvAPjPfjdq3E-3TTF2ja7lLO0nzL9P2Unuhjct9na5b-SYbsOuBwAG9CWvrEVFuEPpzgDZsQX7154zQ</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>NORRIS, Philip J</creator><creator>MOFFETT, Howell F</creator><creator>BRANDER, Christian</creator><creator>ALLEN, Todd M</creator><creator>O'SULLIVAN, Kristin M</creator><creator>COSIMI, Lisa A</creator><creator>KAUFMANN, Daniel E</creator><creator>WALKER, Bruce D</creator><creator>ROSENBERG, Eric S</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040301</creationdate><title>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</title><author>NORRIS, Philip J ; MOFFETT, Howell F ; BRANDER, Christian ; ALLEN, Todd M ; O'SULLIVAN, Kristin M ; COSIMI, Lisa A ; KAUFMANN, Daniel E ; WALKER, Bruce D ; ROSENBERG, Eric S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-3f4c5019309892cb55356596e06db421c484169507fc7c1f9b6537ce6fececc93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Clone Cells</topic><topic>Cross Reactions</topic><topic>Epitope Mapping</topic><topic>Epitopes, T-Lymphocyte - chemistry</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Core Protein p24 - chemistry</topic><topic>HIV Core Protein p24 - genetics</topic><topic>HIV Core Protein p24 - immunology</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - chemistry</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - immunology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Interferon-gamma - metabolism</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Molecular Sequence Data</topic><topic>Peptides - chemistry</topic><topic>Peptides - pharmacology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NORRIS, Philip J</creatorcontrib><creatorcontrib>MOFFETT, Howell F</creatorcontrib><creatorcontrib>BRANDER, Christian</creatorcontrib><creatorcontrib>ALLEN, Todd M</creatorcontrib><creatorcontrib>O'SULLIVAN, Kristin M</creatorcontrib><creatorcontrib>COSIMI, Lisa A</creatorcontrib><creatorcontrib>KAUFMANN, Daniel E</creatorcontrib><creatorcontrib>WALKER, Bruce D</creatorcontrib><creatorcontrib>ROSENBERG, Eric S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS research and human retroviruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NORRIS, Philip J</au><au>MOFFETT, Howell F</au><au>BRANDER, Christian</au><au>ALLEN, Todd M</au><au>O'SULLIVAN, Kristin M</au><au>COSIMI, Lisa A</au><au>KAUFMANN, Daniel E</au><au>WALKER, Bruce D</au><au>ROSENBERG, Eric S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells</atitle><jtitle>AIDS research and human retroviruses</jtitle><addtitle>AIDS Res Hum Retroviruses</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>20</volume><issue>3</issue><spage>315</spage><epage>325</epage><pages>315-325</pages><issn>0889-2229</issn><eissn>1931-8405</eissn><coden>ARHRE7</coden><abstract>Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>15117455</pmid><doi>10.1089/088922204322996554</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0889-2229 |
ispartof | AIDS research and human retroviruses, 2004-03, Vol.20 (3), p.315-325 |
issn | 0889-2229 1931-8405 |
language | eng |
recordid | cdi_proquest_miscellaneous_71879751 |
source | Mary Ann Liebert Online Subscription; MEDLINE; Alma/SFX Local Collection |
subjects | AIDS/HIV Amino Acid Sequence Biological and medical sciences CD4-Positive T-Lymphocytes - immunology Clone Cells Cross Reactions Epitope Mapping Epitopes, T-Lymphocyte - chemistry Epitopes, T-Lymphocyte - immunology Fundamental and applied biological sciences. Psychology HIV Core Protein p24 - chemistry HIV Core Protein p24 - genetics HIV Core Protein p24 - immunology HIV Infections - immunology HIV Infections - virology HIV-1 - chemistry HIV-1 - genetics HIV-1 - immunology Human viral diseases Humans Infectious diseases Interferon-gamma - metabolism Lymphocyte Activation Medical sciences Microbiology Miscellaneous Molecular Sequence Data Peptides - chemistry Peptides - pharmacology Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virology |
title | Fine specificity and cross-clade reactivity of HIV type 1 gag-specific CD4+ T cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A14%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fine%20specificity%20and%20cross-clade%20reactivity%20of%20HIV%20type%201%20gag-specific%20CD4+%20T%20cells&rft.jtitle=AIDS%20research%20and%20human%20retroviruses&rft.au=NORRIS,%20Philip%20J&rft.date=2004-03-01&rft.volume=20&rft.issue=3&rft.spage=315&rft.epage=325&rft.pages=315-325&rft.issn=0889-2229&rft.eissn=1931-8405&rft.coden=ARHRE7&rft_id=info:doi/10.1089/088922204322996554&rft_dat=%3Cproquest_cross%3E71879751%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71879751&rft_id=info:pmid/15117455&rfr_iscdi=true |